Terms: = Uterine cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53
3494 results:
1. A new perspective on Endometrial Carcinoma classification and management strategies in context of molecular subtypes.
Ballová Z; Gašparová P; Sitáš M; Dosedla E
Ceska Gynekol; 2024; 89(2):128-132. PubMed ID: 38704225
[TBL] [Abstract] [Full Text] [Related]
2. The Role of SARS-CoV-2 Spike Protein in the Growth of Cervical cancer Cells.
Willson CM; Lequio M; Zhu Z; Wakefield MR; Bai Q; Fajardo E; Xiao H; Leung S; Fang Y
Anticancer Res; 2024 May; 44(5):1807-1815. PubMed ID: 38677738
[TBL] [Abstract] [Full Text] [Related]
3. Probing the Effects of Retinoblastoma Binding Protein 6 (RBBP6) Knockdown on the Sensitivity of Cisplatin in Cervical cancer Cells.
Mehta H; Ambele MA; Mokgautsi N; Moela P
Cells; 2024 Apr; 13(8):. PubMed ID: 38667315
[TBL] [Abstract] [Full Text] [Related]
4. Deciphering age-specific molecular features in cervical cancer and constructing an angio-immune prognostic model.
Zhao X; Fan X; Lin X; Guo B; Yu Y
Medicine (Baltimore); 2024 Apr; 103(15):e37717. PubMed ID: 38608077
[TBL] [Abstract] [Full Text] [Related]
5. HPLC-ESI/MS-MS metabolic profiling of white pitaya fruit and cytotoxic potential against cervical cancer: Comparative studies, synergistic effects, and molecular mechanistic approaches.
El-Nashar HAS; Al-Azzawi MA; Al-Kazzaz HH; Alghanimi YK; Kocaebli SM; Alhmammi M; Asad A; Salam T; El-Shazly M; Ali MAM
J Pharm Biomed Anal; 2024 Jul; 244():116121. PubMed ID: 38581932
[TBL] [Abstract] [Full Text] [Related]
6. Molecular characterization as new driver in prognostic signatures and therapeutic strategies for endometrial cancer.
D'Agostino E; Mastrodomenico L; Ponzoni O; Baldessari C; Piombino C; Pipitone S; Giuseppa Vitale M; Sabbatini R; Dominici M; Toss A
Cancer Treat Rev; 2024 May; 126():102723. PubMed ID: 38555857
[TBL] [Abstract] [Full Text] [Related]
7. Establishment and characterization of multiple patient-derived organoids from a case of advanced endometrial cancer.
Maru Y; Kohno M; Suzuka K; Odaka A; Masuda M; Araki A; Itami M; Tanaka N; Hippo Y
Hum Cell; 2024 May; 37(3):840-853. PubMed ID: 38546950
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathological Significance of Nucleosome Remodeling and Deacetylase Complex Expression in Endometrial Carcinoma.
Chu J; Lee SH; DO SI; Kim HS
Anticancer Res; 2024 Apr; 44(4):1739-1750. PubMed ID: 38538000
[TBL] [Abstract] [Full Text] [Related]
9. PAD-mediated citrullination is a novel candidate diagnostic marker and druggable target for HPV-associated cervical cancer.
Albano C; Biolatti M; Mazibrada J; Pasquero S; Gugliesi F; Lo Cigno I; Calati F; Bajetto G; Riva G; Griffante G; Landolfo S; Gariglio M; De Andrea M; Dell'Oste V
Front Cell Infect Microbiol; 2024; 14():1359367. PubMed ID: 38529474
[TBL] [Abstract] [Full Text] [Related]
10. Biomarker characterization in endometrial cancer in Europe: first survey data analysis from 69 pathological academic and hospital labs.
Santoro A; Bragantini E; Castiglione F; Ganesan R; Matias-Guiu X; Frattini M; Gallotta V; Garcia P; Pattni Y; Tsiampali-Laprell J; Bisaro B; Barbareschi M; Zannoni GF;
Pathologica; 2024 Feb; 116(1):32-45. PubMed ID: 38482673
[TBL] [Abstract] [Full Text] [Related]
11. Genomic profile analysis of leiomyomas with bizarre nuclei and fumarate hydratase deficient leiomyomas: Strengths, weaknesses, and limitations of array-CGH interpretation.
Fontanges Q; Dubos P; Lesluyes T; Laizet Y; Velasco V; Meléndez B; D'Haene N; Oliva E; Young RH; Mayeur L; Rebier F; Alamé M; Larmonier C; Devouassoux-Shisheboran M; Arnould L; Soubeyran I; Chakiba C; Floquet A; Babin G; Guyon F; Mery E; Le Guellec S; Noël JC; Croce S; Chibon F
Genes Chromosomes Cancer; 2024 Mar; 63(3):e23229. PubMed ID: 38481055
[TBL] [Abstract] [Full Text] [Related]
12. Downregulation of LAMB3 Altered the Carcinogenic Properties of Human Papillomavirus 16-Positive Cervical cancer Cells.
Wattanathavorn W; Seki M; Suzuki Y; Buranapraditkun S; Kitkumthorn N; Sasivimolrattana T; Bhattarakosol P; Chaiwongkot A
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473784
[TBL] [Abstract] [Full Text] [Related]
13. Linoleic acid exhibits anti-proliferative and anti-invasive activities in endometrial cancer cells and a transgenic model of endometrial cancer.
Qiu J; Zhao Z; Suo H; Paraghamian SE; Hawkins GM; Sun W; Zhang X; Hao T; Deng B; Shen X; Zhou C; Bae-Jump V
Cancer Biol Ther; 2024 Dec; 25(1):2325130. PubMed ID: 38465855
[TBL] [Abstract] [Full Text] [Related]
14. Detection of driver mutations and genomic signatures in endometrial cancers using artificial intelligence algorithms.
Stan A; Bosart K; Kaur M; Vo M; Escorcia W; Yoder RJ; Bouley RA; Petreaca RC
PLoS One; 2024; 19(2):e0299114. PubMed ID: 38408048
[TBL] [Abstract] [Full Text] [Related]
15. LOC644656 promotes cisplatin resistance in cervical cancer by recruiting ZNF143 and activating the transcription of E6-AP.
Li M; Chen J; Zhang H; Zhang Y; Wang J; Shen Z; Chen Y; Hou W; Chi C
Cell Signal; 2024 May; 117():111115. PubMed ID: 38395183
[TBL] [Abstract] [Full Text] [Related]
16. Evaluation of the anti-cancer efficacy of lipid nanoparticles containing siRNA against HPV16 E6/E7 combined with cisplatin in a xenograft model of cervical cancer.
Kang SW; Kang OJ; Lee JY; Kim H; Jung H; Kim H; Lee SW; Kim YM; Choi EK
PLoS One; 2024; 19(2):e0298815. PubMed ID: 38363779
[TBL] [Abstract] [Full Text] [Related]
17. To study the expression of estrogen, progesterone receptor and p53 immunohistochemistry markers in subtyping endometrial carcinoma.
Yadav A; Sistla A; Swain M; Gowrishankar S; Padua M; Modi T; Himabindu R; Agarwal N; Kulkarni A; Bhandari T; Vudayaraju H; Chinnababu ; Reddy VA
Indian J Pathol Microbiol; 2024; 67(1):62-67. PubMed ID: 38358190
[TBL] [Abstract] [Full Text] [Related]
18. Temporal regulation of gene expression and pathways in chemotherapy-induced senescence in HeLa cervical cancer cell line.
Sucularli C; Şimay Demir YD; Özdemir A; Ark M
Biosystems; 2024 Mar; 237():105140. PubMed ID: 38336224
[TBL] [Abstract] [Full Text] [Related]
19. Impact of molecular profile on prognosis and relapse pattern in low and intermediate risk endometrial cancer.
Lindemann K; Kildal W; Kleppe A; Tobin KAR; Pradhan M; Isaksen MX; Vlatkovic L; Danielsen HE; Kristensen GB; Askautrud HA
Eur J Cancer; 2024 Mar; 200():113584. PubMed ID: 38330767
[TBL] [Abstract] [Full Text] [Related]
20. Gold nanoparticles (AuNPs) decrease the viability of cervical cancer cells by inducing the BAX gene and activating antioxidant enzymes.
Kamil Shareef NA; Zandsalimi F; Tavoosidana G
Mol Biol Rep; 2024 Feb; 51(1):287. PubMed ID: 38329621
[TBL] [Abstract] [Full Text] [Related]
[Next]